Filing excerpt
Significant innovation including the market authorization of OTTAVA as the world’s first table-integrated soft tissue robotic system
sec.gov/Archives/edgar/data/200406/000020040626000189/jnj-20261013.htmRead the full source
Johnson & Johnson8-K: Product launch
FDA Grants Market Authorization for OTTAVA Soft Tissue Robotic Surgical System
What happened
JNJ received U.S. FDA market authorization for OTTAVA, marking commercial launch readiness for its table-integrated robotic surgery system and driving operational rollout across hospital networks.
Source
Other signals in this filing (4)
- Succession announcementTom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Replacing Retiring Jennifer TaubertSuccession announcement
- Restructuring chargeJohnson & Johnson Incurs $181M Q3 Restructuring Charge as Part of $650M-$750M Supply Chain OptimizationRestructuring charge
- RestructuringJ&J Initiates $650M-$750M Supply Chain Restructuring Exiting Manufacturing Sites Through 2029Restructuring
- Acquisition completedJohnson & Johnson Completes Acquisition of Firefly Bio to Expand Oncology PipelineAcquisition completed
Extracted by Autobound
From the Signal API record- Signal
- 8-K: Product launch
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Fiscal year end
- 10/13
- Filed
- Oct 13, 2026
More from Johnson & Johnson
- In developmentJohnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancerIn development
- Spin-offSmith & Nephew talks with J&J on orthopaedics deal fail over CEO role, source saysSpin-off
- 10-QRecorded $5.5 billion charge for proposed talc ovarian litigation resolution10-Q
- PatentsJohnson & Johnson Surgical Vision, Inc.'s patent output is steady: 33 grants in the past year, 3 in the past 30 days.Patents
- 8-KTom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Replacing Retiring Jennifer Taubert8-K
- Web trafficjnj.com received 3M monthly visits with traffic from 5 countries.Web traffic
More 8-K signals at other companies
- SEC 8-KAAR Corp.AAR Corp. amends credit facility to permit pending acquisition of MRO HoldingsSEC 8-K
- SEC 8-KBlue Ridge Bankshares, Inc.Blue Ridge Bankshares announced definitive merger agreement with HomeTrust Bancshares anticipated closing Q1 2027SEC 8-K
- SEC 8-KBoston Omaha CorporationBoston Omaha Completes $84.3M Sale of Surety Insurance Business Unit GIGSEC 8-K
The full record
From the Signal API recordDetails
- CIK
- 200406
- Accession number
- 0000200406-26-000189
- Timeframe
- Current quarter
- Filing year
- 2026
- Why it matters
- Go-to-market support
- Signal category
- Strategic
Topics and mentions
Technologies
- surgical robotics
- OTTAVA Robotic Surgical System
Regions named
- U.S.
Extraction
- Confidence
- High
- Relevance
- 80%
- Sentiment
- Positive
- Detected
- Oct 20, 2026
- signal_type
sec-8k- signal_subtype
productLaunch
Use this data
Get every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
Send it to your own tools
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/15e4596f-1ae6-4706-91c4-999e525a262d returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "15e4596f-1ae6-4706-91c4-999e525a262d",
"signal_type": "sec-8k",
"signal_subtype": "productLaunch",
"detected_at": "2026-10-20T07:04:03.335+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "JNJ received U.S. FDA market authorization for OTTAVA, marking commercial launch readiness for its table-integrated robotic surgery system and driving operational rollout across hospital networks.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "FDA Grants Market Authorization for OTTAVA Soft Tissue Robotic Surgical System",
"excerpts": "Significant innovation including the market authorization of OTTAVA as the world’s first table-integrated soft tissue robotic system",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000189/jnj-20261013.htm",
"filing_date": "2026-10-13",
"filing_year": 2026,
"fiscal_year_end": "10/13",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
],
"technologies_mentioned": [
"surgical robotics",
"OTTAVA Robotic Surgical System"
]
}
}
curl https://signals.autobound.ai/v1/signals/15e4596f-1ae6-4706-91c4-999e525a262d \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.